Protein distribution in a tissue sample's cells can be assessed by an approach called immunohistochemistry (IHC). Through the use of particular antibodies that attach to proteins, pathologists are able to visually determine the location, size, and presence of specific proteins.
Profile Name IHC - Final diagnosis panel with histopathology
Sample Type Tissue
Preparations Required There are no specific instructions for patients for this test. Preparation is typically handled by the medical professionals collecting the tissue sample.
Report Time 5 days
Up to five distinct antibodies are used in the IHC final diagnosis panel with histopathology, depending on the patient's specific diagnostic requirements. When combined with histopathology, which examines the microscopic organization of diseased tissues, it offers a comprehensive understanding of the illness at the cellular level. This data is critical for the diagnosis of many conditions, including cancers, and informs treatment choices.
The IHC histopathology final diagnosis panel aims to detect and locate specific proteins in a tissue sample to help diagnose disease. It can identify different types of cancer, inflammation, or infection in the body.
At Sprint Diagnostics, our pathologists perform Histopathology final diagnosis panel with up to 5 antibodies using modern technologies and assess the condition accurately. The IHC final diagnosis panel price, along with the expertise of our pathologists, is truly valuable. Schedule your appointment today.
Home Sample Collection Process
1
Book your convenient slot
2
Sample Collection by Phlebotomist
3
Reporting of the sample at lab
4
Download Reports
Note: Home Sample Collection is only for Pathology lab tests.
Frequently Asked Questions
The IHC final diagnosis panel aims to detect and locate specific proteins in a tissue sample to help
diagnose disease. It can identify different types of cancer, inflammation, or infection in the body.
The number of antibodies used depends on the suspected disease and the specific proteins associated with
it. Using up to five antibodies allows for a thorough investigation without overloading the sample or
complicating the results.
While the IHC test can help identify specific types of cancer and provide information on the
characteristics of the cancer cells, it's not typically used to determine the stage of cancer. Other
tests and examinations are needed for staging.
While this test is frequently used in diagnosing different types of cancers, it's also used for
diagnosing other conditions, such as autoimmune diseases and infectious diseases.
Yes, the results can guide treatment decisions, particularly in the case of cancers where the presence or
absence of specific proteins can impact the choice of therapy.
